Reply #39: Merck cleared in N.J. Vioxx trial [View All]

[RawMaterials]

The verdict left Merck, which voluntarily pulled the drug off the market last year, with one win and one defeat in the first two Vioxx trials.

The case, which is the second Vioxx lawsuit to go to trial, took seven weeks to present, with complex testimony about the inner workings of the heart and detailed descriptions about the clinical studies Merck conducted before and after it began selling Vioxx in 1999.

Merck lost the first trial over Vioxx when a Texas jury awarded $253 million in damages to the widow of a Vioxx user. Texas law requires that award to be cut to no more than $26 million. Merck plans to appeal.




http://www.msnbc.msn.com/id/9910674/